Home›Companies›Healthcare›Alethios

Alethios Inc.

Software for researchers to design and run remote human health studies.

Updated Nov 9, 2026·Latest SEC filing Oct 2, 2026·Suggest an edit

About Alethios

Alethios is a private company based in San Francisco, California, incorporated in 2023 in Delaware. It has reported $2,339,962 raised in two offerings on Form D since July 2024. Its chief executive is Zeenia Framroze.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Sep 29, 2026Oct 2, 2026$2,169,962of $2.1M target17$127KEquityRule 506(b)Form D ↗
Jul 3, 2024Jul 9, 2024$170,000of $600K target5$34,000Options, Securities on exerciseRule 506(b)Form D ↗
Total, two offerings$2,339,962

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Alethios's Form D filed Oct 2, 2026.

Sources

  1. SECAlethios Inc. filing history
  2. CompanyPrivacy Policy
  3. CompanyAbout Alethios